Evidence map›Paper›PMID 40072642›Full record

ArticleArchives of dermatological research2025

Assessment of androgenic hormones and other risk factors in Egyptian males with early onset androgenetic alopecia: a case control study.

Manal A Sharara, Esraa M Elfeki, Naziha H Khafagy

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of dermatological research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Manal A ShararaAin Shams University, Cairo, Egypt. manalsharara@med.asu.edu.eg.
Esraa M ElfekiAin Shams University, Cairo, Egypt.
Naziha H KhafagyAin Shams University, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Early-onset androgenetic alopecia (AGA) is a common, hereditary hair loss condition in men, often starting in the early twenties. It involves gradual thinning of hair, influenced by genetics, hormones, and other factors like smoking and family history. Early identification of these risks could support timely intervention. This case control study aimed to evaluate androgen levels, specifically the free androgen index(FAI) and dehydroepiandrosterone sulfate ( DHEA-S), in males with early-onset AGA versus healthy age and sex matched controls. It also determined risk factors contributing to premature AGA in Egyptian males. This study included 40 male patients between 18 and 30 years with early-onset AGA and 40 age-matched healthy male controls. Risk factors and hormonal profiles including sex hormone binding globulin (SHBG), total testosterone (TS), DHEA-S as well as calculated FAI were compared between both groups using ELISA kit. Our study found that early-onset AGA is linked to a strong family history, smoking, coffee intake, hair straightener use, fast-food diets, and recent weight gain. Early-onset AGA patients also showed statistically significant lower SHBG levels and higher TS, DHEAS and FAI compared to healthy controls. These findings suggest that early-onset AGA is shaped by a complex interaction of different factors, highlighting the importance of a comprehensive approach and advice to patients as regards different risk factors.

Indexed as

AlopeciaAndrogensDehydroepiandrosterone SulfateTestosteroneAdolescentAdultAge of OnsetCase-Control StudiesEgyptHairHumansMaleRisk FactorsSex Hormone-Binding GlobulinSmokingYoung AdultAndrogensDehydroepiandrosterone SulfateSex Hormone-Binding GlobulinTestosteroneAndrogenetic alopeciaDHEA-SRisk factorsSHBGTS

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.